Found: 2
Select item for more details and to access through your institution.
A double-blind, placebo-controlled, randomized trial of XP-828L (800 mg) on the quality of life and clinical symptoms of patients with mild-to-moderate psoriasis.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
XP-828L in the treatment of mild-to-moderate psoriasis: a randomized, double-blind, placebo-controlled study.
- Published in:
- 2007
- By:
- Publication type:
- Journal Article